-
Something wrong with this record ?
FADS Polymorphisms Affect the Clinical and Biochemical Phenotypes of Metabolic Syndrome
A. Žák, M. Jáchymová, M. Burda, B. Staňková, M. Zeman, A. Slabý, M. Vecka, O. Šeda
Language English Country Switzerland
Document type Journal Article
Grant support
MH CZ DRO-VFN64165
the Ministry of Health of the Czech Republic
"Cooperatio - Gastroenterology"
the Charles University Research program
NLK
Directory of Open Access Journals
from 2011
Free Medical Journals
from 2011
PubMed Central
from 2011
Europe PubMed Central
from 2011
ProQuest Central
from 2011-01-01
Open Access Digital Library
from 2011-01-01
Open Access Digital Library
from 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2011
- Publication type
- Journal Article MeSH
Long-chain polyunsaturated fatty acids (LC-PUFAs) play important roles in human health, from controlling inflammation to lipid and glucose homeostasis. In our previous study, which employed a cluster analysis of a plasma fatty acid (FA) pattern, we identified two clusters of metabolic syndrome (MetS) independent of clinical and biochemical parameters within the whole study group (controls together with metabolic syndrome (MetS) patients). FA desaturase (FADS) genes are the key regulators of LC-PUFA metabolism. The aim of this study was to analyze associations between FADS polymorphisms and clusters of MetS. The study group consisted of 188 controls and 166 patients with MetS. The first cluster contained 71 controls (CON1) and 109 MetS patients (MetS1). The second cluster consisted of 117 controls (CON2) and 57 MetS patients (MetS2). In comparison with MetS2, cluster MetS1 displayed a more adverse risk profile. Cluster CON1 had, in comparison with CON2, higher body weight and increased triacylglycerol levels (p < 0.05). We found that the FADS rs174537 (p < 0.001), rs174570 (p < 0.01), and rs174602 (p < 0.05) polymorphisms along with two inferred haplotypes had statistically significant genotype associations with the splitting of MetS into MetS1 and MetS2. Conversely, we observed no significant differences in the distribution of FADS polymorphisms between MetS and CON subjects, or between CON1 and CON2. These associations between FADS polymorphisms and two clusters of MetS (differing in waist circumference, HOMA-IR, lipolysis, and oxidative stress) implicate the important influence of genetic factors on the phenotypic manifestation of MetS.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22016958
- 003
- CZ-PrNML
- 005
- 20220720100041.0
- 007
- ta
- 008
- 220718s2022 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/metabo12060568 $2 doi
- 035 __
- $a (PubMed)35736500
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Žák, Aleš $u 4th Department of Medicine, 1st Medical Faculty, Charles University and the General University Hospital in Prague, 128 08 Prague, Czech Republic
- 245 10
- $a FADS Polymorphisms Affect the Clinical and Biochemical Phenotypes of Metabolic Syndrome / $c A. Žák, M. Jáchymová, M. Burda, B. Staňková, M. Zeman, A. Slabý, M. Vecka, O. Šeda
- 520 9_
- $a Long-chain polyunsaturated fatty acids (LC-PUFAs) play important roles in human health, from controlling inflammation to lipid and glucose homeostasis. In our previous study, which employed a cluster analysis of a plasma fatty acid (FA) pattern, we identified two clusters of metabolic syndrome (MetS) independent of clinical and biochemical parameters within the whole study group (controls together with metabolic syndrome (MetS) patients). FA desaturase (FADS) genes are the key regulators of LC-PUFA metabolism. The aim of this study was to analyze associations between FADS polymorphisms and clusters of MetS. The study group consisted of 188 controls and 166 patients with MetS. The first cluster contained 71 controls (CON1) and 109 MetS patients (MetS1). The second cluster consisted of 117 controls (CON2) and 57 MetS patients (MetS2). In comparison with MetS2, cluster MetS1 displayed a more adverse risk profile. Cluster CON1 had, in comparison with CON2, higher body weight and increased triacylglycerol levels (p < 0.05). We found that the FADS rs174537 (p < 0.001), rs174570 (p < 0.01), and rs174602 (p < 0.05) polymorphisms along with two inferred haplotypes had statistically significant genotype associations with the splitting of MetS into MetS1 and MetS2. Conversely, we observed no significant differences in the distribution of FADS polymorphisms between MetS and CON subjects, or between CON1 and CON2. These associations between FADS polymorphisms and two clusters of MetS (differing in waist circumference, HOMA-IR, lipolysis, and oxidative stress) implicate the important influence of genetic factors on the phenotypic manifestation of MetS.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Jáchymová, Marie $u Institute of Clinical Chemistry and Laboratory Diagnostics, 1st Medical Faculty, Charles University and the General University Hospital in Prague, 128 08 Prague, Czech Republic
- 700 1_
- $a Burda, Michal $u Institute for Research and Applications of Fuzzy Modeling, University of Ostrava, 701 03 Ostrava, Czech Republic $1 https://orcid.org/0000000241824407
- 700 1_
- $a Staňková, Barbora $u 4th Department of Medicine, 1st Medical Faculty, Charles University and the General University Hospital in Prague, 128 08 Prague, Czech Republic
- 700 1_
- $a Zeman, Miroslav $u 4th Department of Medicine, 1st Medical Faculty, Charles University and the General University Hospital in Prague, 128 08 Prague, Czech Republic
- 700 1_
- $a Slabý, Adolf $u 4th Department of Medicine, 1st Medical Faculty, Charles University and the General University Hospital in Prague, 128 08 Prague, Czech Republic
- 700 1_
- $a Vecka, Marek $u 4th Department of Medicine, 1st Medical Faculty, Charles University and the General University Hospital in Prague, 128 08 Prague, Czech Republic $u Institute of Clinical Chemistry and Laboratory Diagnostics, 1st Medical Faculty, Charles University and the General University Hospital in Prague, 128 08 Prague, Czech Republic $1 https://orcid.org/0000000232691817 $7 xx0076497
- 700 1_
- $a Šeda, Ondřej $u Institute of Biology and Medical Genetics, 1st Medical Faculty, Charles University and the General University Hospital in Prague, 128 00 Prague, Czech Republic $1 https://orcid.org/0000000184985895 $7 xx0070901
- 773 0_
- $w MED00193532 $t Metabolites $x 2218-1989 $g Roč. 12, č. 6 (2022)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35736500 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20220718 $b ABA008
- 991 __
- $a 20220720100037 $b ABA008
- 999 __
- $a ind $b bmc $g 1816385 $s 1168200
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 12 $c 6 $e 20220620 $i 2218-1989 $m Metabolites $n Metabolites $x MED00193532
- GRA __
- $a MH CZ DRO-VFN64165 $p the Ministry of Health of the Czech Republic
- GRA __
- $a "Cooperatio - Gastroenterology" $p the Charles University Research program
- LZP __
- $a Pubmed-20220718